PGDx Elio组织完整检测（PGDx Elio Tissue Complete）是一种新兴的肿瘤诊断技术。2020年4月，美国FDA批准了Personal Genome Diagnostics公司的 PGDx Elio Tissue Complete产品的510(K)上市申请。PGDx Elio Tissue Complete是FDA认证的一款肿瘤NGS大panel产品（507基因，全长2.23Mb，CDS区约1.33Mb），可检测癌症组织...
PGDx Elio组织完整检测(PGDx Elio Tissue Complete)是一种新兴的肿瘤诊断技术。2020年4月,美国FDA批准了Personal Genome Diagnostics公司的 PGDx Elio Tissue Complete产品的510(K)上市申请。PGDx Elio Tissue Complete是FDA认证的一款肿瘤NGS大panel产品(507基因,全长2.23Mb,CDS区约1.33Mb),可检测癌症组织中507个癌...
当与PGDx elio tissue complete配合使用时,Labcorp现在允许实验室访问在同一台仪器上运行的组织和液体基因组图谱分析,从而将这些精密肿瘤学产品无缝集成到常规实验室工作流程中。测试组织或液体的能力将提供所需的关键数据和见解,为患者提供更个性化的治疗和护理计划。”...
PGDx elio tissue complete产品名称,K192063申请号,510k申请类型,Personal Genome Diagnostics申请人,数据来源于药智数据美国上市器械数据库。
PGDx CEO Megan Bailey said: “PGDx elio tissue complete responds to this unmet need by bringing genomic cancer testing of the highest quality directly to healthcare providers. “Since the founding of our company we have been united in our mission to empower the fight against ...
The PGDx elio tissue complete panel is a 507-gene test for somatic alterations that is designed to detect SNVs, indels, amplifications, rearrangements, MSI, and TMB.
In 2021, our institution implemented PGDx elio tissue complete (PGDx), introducing redundancy in ROS1 translocation testing, previously assessed by FISH through send-out testing to Mayo Clinic. The objective of this study was to perform a retrospective analysis of our molecular testing experience ...